Literature DB >> 18309012

Whole-body high-field-strength (3.0-T) MR Imaging in Clinical Practice. Part I. Technical considerations and clinical applications.

Christiane K Kuhl1, Frank Träber, Hans H Schild.   

Abstract

In the year 2002, magnetic field strength of more than 2 T was cleared for clinical patient care. Since then, an increasing number of magnetic resonance (MR) systems operating at a field strength of 3.0 T (and higher) have been installed worldwide. This article is the first of a two-part series on clinical high-field-strength MR imaging. Some basic physical effects of higher magnetic fields as they pertain to clinical MR imaging and spectroscopy are reviewed, from the perspective of a clinical radiologist, and strategies that are useful to avoid magnetic field-related difficulties and artifacts are discussed. Advantages and downsides, which can be expected for clinical MR, are presented and compared with the current level of evidence based on published data about MR of the brain and MR angiography. In the second part of the series, clinical applications regarding cardiac, breast, musculoskeletal, abdominopelvic, and pediatric MR and MR spectroscopy will be presented. (c) RSNA, 2008.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18309012     DOI: 10.1148/radiol.2463060881

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  32 in total

1.  Cardiac magnetic resonance: is phonocardiogram gating reliable in velocity-encoded phase contrast imaging?

Authors:  Kai Nassenstein; Stephan Orzada; Lars Haering; Andreas Czylwik; Christoph Jensen; Thomas Schlosser; Oliver Bruder; Mark E Ladd; Stefan Maderwald
Journal:  Eur Radiol       Date:  2012-07-10       Impact factor: 5.315

2.  Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer.

Authors:  Huaijun Wang; Guy Marchal; Yicheng Ni
Journal:  World J Radiol       Date:  2011-01-28

3.  Evidence-based radiology: why and how?

Authors:  Francesco Sardanelli; Myriam G Hunink; Fiona J Gilbert; Giovanni Di Leo; Gabriel P Krestin
Journal:  Eur Radiol       Date:  2010-01       Impact factor: 5.315

4.  Contrast-enhanced MR imaging of the breast: association between asymmetric increased breast vascularity and ipsilateral cancer in a consecutive series of 197 patients.

Authors:  N Verardi; G Di Leo; L A Carbonaro; M P Fedeli; F Sardanelli
Journal:  Radiol Med       Date:  2012-08-08       Impact factor: 3.469

5.  3-T MRI safety assessments of magnetic dental attachments and castable magnetic alloys.

Authors:  M Hasegawa; K Miyata; Y Abe; T Ishii; T Ishigami; K Ohtani; E Nagai; T Ohyama; Y Umekawa; S Nakabayashi
Journal:  Dentomaxillofac Radiol       Date:  2015-03-18       Impact factor: 2.419

6.  Linear sign in cystic brain lesions ≥5 mm: A suggestive feature of perivascular space.

Authors:  Jinkyeong Sung; Jinhee Jang; Hyun Seok Choi; So-Lyung Jung; Kook-Jin Ahn; Bum-Soo Kim
Journal:  Eur Radiol       Date:  2017-05-24       Impact factor: 5.315

7.  Clinical safety of 3-T brain magnetic resonance imaging in newborns.

Authors:  Monica Fumagalli; Claudia Maria Cinnante; Sonia Francesca Calloni; Gabriele Sorrentino; Ilaria Gorla; Laura Plevani; Nicola Pesenti; Ida Sirgiovanni; Fabio Mosca; Fabio Triulzi
Journal:  Pediatr Radiol       Date:  2018-03-29

8.  Effect of orthodontic brackets and different wires on radiofrequency heating and magnetic field interactions during 3-T MRI.

Authors:  S Görgülü; S Ayyildiz; K Kamburoglu; S Gökçe; T Ozen
Journal:  Dentomaxillofac Radiol       Date:  2013-11-20       Impact factor: 2.419

9.  Ocular volumetry using fast high-resolution MRI during visual fixation.

Authors:  K Tanitame; T Sone; T Miyoshi; N Tanitame; K Otani; Y Akiyama; M Takasu; S Date; Y Kiuchi; K Awai
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-04       Impact factor: 3.825

10.  Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla.

Authors:  Birgit Simon; Stephan Schmidt; Carsten Lukas; Jürgen Gieseke; Frank Träber; Dirk L Knol; Winfried A Willinek; Jeroen J G Geurts; Hans H Schild; Frederik Barkhof; Mike P Wattjes
Journal:  Eur Radiol       Date:  2010-01-22       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.